{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:32:41Z","timestamp":1773275561918,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/mnm.0b013e3282f813e1","type":"journal-article","created":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T07:05:45Z","timestamp":1212044745000},"page":"636-641","source":"Crossref","is-referenced-by-count":20,"title":["Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma"],"prefix":"10.1097","volume":"29","author":[{"given":"Marc D.","family":"Zuijdwijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter V.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans H.M.","family":"Corstens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim J.G.","family":"Oyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210212","first-page":"221","article-title":"18F-FDG PET\/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer","volume":"48","author":"Shammas","year":"2007","journal-title":"J Nucl Med"},{"key":"R2-9-20210212","first-page":"616","article-title":"Integrated PET\/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management","volume":"47","author":"Palmedo","year":"2006","journal-title":"J Nucl Med"},{"key":"R3-9-20210212","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF03026819","article-title":"The clinical impact of 18F-FDG PET in papillary thyroid carcinoma with a negative 131I whole body scan: a single-center study of 108 patients","volume":"20","author":"Choi","year":"2006","journal-title":"Ann Nucl Med"},{"key":"R4-9-20210212","first-page":"1464","article-title":"Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy","volume":"42","author":"Helal","year":"2001","journal-title":"J Nucl Med"},{"key":"R5-9-20210212","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11307-006-0046-3","article-title":"2-Deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and positron emission tomography\/computed tomography diagnosis of patients with recurrent papillary thyroid cancer","volume":"8","author":"Iagaru","year":"2006","journal-title":"Mol Imaging Biol"},{"key":"R6-9-20210212","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s002590050493","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study","volume":"26","author":"Grunwald","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"R7-9-20210212","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1210\/jcem.84.7.5827","article-title":"[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels","volume":"84","author":"Wang","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-9-20210212","first-page":"1468","article-title":"Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer","volume":"37","author":"Feine","year":"1996","journal-title":"J Nucl Med"},{"key":"R9-9-20210212","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.mlg.0000154725.00787.00","article-title":"The role of positron emission tomography\/computed tomography in the management of recurrent papillary thyroid carcinoma","volume":"115","author":"Nahas","year":"2005","journal-title":"Laryngoscope"},{"key":"R10-9-20210212","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00259-003-1403-y","article-title":"Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer","volume":"31","author":"Iwata","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-9-20210212","first-page":"71","article-title":"Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan","volume":"42","author":"Schluter","year":"2001","journal-title":"J Nucl Med"},{"key":"R12-9-20210212","first-page":"1260","article-title":"Diagnostic accuracy and prognostic value of 18F-FDG PET in Hurthle cell thyroid cancer patients","volume":"47","author":"Pryma","year":"2006","journal-title":"J Nucl Med"},{"key":"R13-9-20210212","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4158\/EP.12.2.152","article-title":"Role of [18F]fluorodeoxyglucose positron emission tomography in follow-up of differentiated thyroid cancer","volume":"12","author":"Alzahrani","year":"2006","journal-title":"Endocr Pract"},{"key":"R14-9-20210212","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/00006231-200309000-00003","article-title":"The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma","volume":"24","author":"Goshen","year":"2003","journal-title":"Nucl Med Commun"},{"issue":"3C","key":"R15-9-20210212","first-page":"2973","article-title":"Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography","volume":"23","author":"Wu","year":"2003","journal-title":"Anticancer Res"},{"key":"R16-9-20210212","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1081\/ERC-120022297","article-title":"F18-fluorodeoxyglucose positron emission tomography in detecting metastatic papillary thyroid carcinoma with elevated human serum thyroglobulin levels but negative 131I whole body scan","volume":"29","author":"Hung","year":"2003","journal-title":"Endocr Res"},{"key":"R17-9-20210212","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/105072502753522392","article-title":"Implication of 2\u201318fluor-2-deoxyglucose positron emission tomography in the follow-up of Hurthle cell thyroid cancer","volume":"12","author":"Plotkin","year":"2002","journal-title":"Thyroid"},{"key":"R18-9-20210212","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9610(00)00381-0","article-title":"Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels","volume":"179","author":"Muros","year":"2000","journal-title":"Am J Surg"},{"key":"R19-9-20210212","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/thy.1999.9.797","article-title":"Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography","volume":"9","author":"Conti","year":"1999","journal-title":"Thyroid"},{"key":"R20-9-20210212","first-page":"986","article-title":"Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan","volume":"40","author":"Chung","year":"1999","journal-title":"J Nucl Med"},{"key":"R21-9-20210212","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s004230050109","article-title":"Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans","volume":"383","author":"Altenvoerde","year":"1998","journal-title":"Langenbecks Arch Surg"},{"key":"R22-9-20210212","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00006231-199806000-00006","article-title":"Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography","volume":"19","author":"Jadvar","year":"1998","journal-title":"Nucl Med Commun"},{"key":"R23-9-20210212","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/00000658-200112000-00012","article-title":"Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma","volume":"234","author":"Frilling","year":"2001","journal-title":"Ann Surg"},{"key":"R24-9-20210212","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/1097-0347(200102)23:2<94::AID-HED1004>3.0.CO;2-R","article-title":"F-18-fluorodeoxyglucose positron emission tomography as a presurgical evaluation modality for 131I scan-negative thyroid carcinoma patients with local recurrence in cervical lymph nodes","volume":"23","author":"Yeo","year":"2001","journal-title":"Head Neck"},{"key":"R25-9-20210212","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.RLU.0000053409.18088.46","article-title":"In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging","volume":"28","author":"Sarlis","year":"2003","journal-title":"Clin Nucl Med"},{"key":"R26-9-20210212","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/thy.1997.7.327","article-title":"Comparison of 18FDG-PET with 131iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer","volume":"7","author":"Grunwald","year":"1997","journal-title":"Thyroid"},{"key":"R27-9-20210212","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF00837630","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer","volume":"23","author":"Grunwald","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"R28-9-20210212","first-page":"414","article-title":"Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma","volume":"42","author":"Shiga","year":"2001","journal-title":"J Nucl Med"},{"issue":"5b","key":"R29-9-20210212","first-page":"4235","article-title":"Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative 131I whole body scan","volume":"23","author":"Wu","year":"2003","journal-title":"Anticancer Res"},{"key":"R30-9-20210212","first-page":"1402","article-title":"18F-FDG PET of patients with Hurthle cell carcinoma","volume":"44","author":"Lowe","year":"2003","journal-title":"J Nucl Med"},{"key":"R31-9-20210212","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1076-6332(03)00014-X","article-title":"Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma","volume":"10","author":"Chen","year":"2003","journal-title":"Acad Radiol"},{"key":"R32-9-20210212","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00259-003-1401-0","article-title":"Influence of TSH on uptake of [18F]fluorodeoxyglucose in human thyroid cells in vitro","volume":"31","author":"Deichen","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R33-9-20210212","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/105072502760043459","article-title":"Better yield of (18)fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation","volume":"12","author":"Van Tol","year":"2002","journal-title":"Thyroid"},{"key":"R34-9-20210212","first-page":"1989","article-title":"Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma","volume":"41","author":"Moog","year":"2000","journal-title":"J Nucl Med"},{"key":"R35-9-20210212","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/thy.2006.16.267","article-title":"Thyroid-stimulating hormone-stimulated fused positron emission tomography\/computed tomography in the evaluation of recurrence in 131I-negative papillary thyroid carcinoma","volume":"16","author":"Saab","year":"2006","journal-title":"Thyroid"},{"key":"R36-9-20210212","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/jc.2003-031027","article-title":"Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma","volume":"89","author":"Chin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-9-20210212","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00259-001-0745-6","article-title":"Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma","volume":"29","author":"Petrich","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R38-9-20210212","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00259-006-0276-2","article-title":"Combined PET\/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?","volume":"34","author":"Zoller","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R39-9-20210212","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.biopha.2006.07.008","article-title":"Role of 18F-FDG-PET and PET\/CT imaging in thyroid cancer","volume":"60","author":"Nanni","year":"2006","journal-title":"Biomed Pharmacother"},{"key":"R40-9-20210212","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.semnuclmed.2006.03.002","article-title":"Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer","volume":"36","author":"Lind","year":"2006","journal-title":"Semin Nucl Med"},{"key":"R41-9-20210212","first-page":"1010","article-title":"FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma","volume":"41","author":"Alnafisi","year":"2000","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006231-200807000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:45:01Z","timestamp":1618037101000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-200807000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e3282f813e1","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}